We are live on ! Find out more
LAB icon

Standard BioTools

104 hedge funds and large institutions have $1.29B invested in Standard BioTools in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 36 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

26% more capital invested

Capital invested by funds: $1.02B → $1.29B (+$264M)

11% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 36

4% more funds holding

Funds holding: 100104 (+4)

32% less call options, than puts

Call options by funds: $1.09M | Put options by funds: $1.6M

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
104
Holders Change
+4
Holders Change %
+4%
% of All Funds
2.77%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
16
Increased
40
Reduced
36
Closed
11
Calls
$1.09M
Puts
$1.6M
Net Calls
-$504K
Net Calls Change
-$141K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$7.97M +$509K +12,874 +7%
FC
27
FIC Capital
New York
$7.94M
Geode Capital Management
28
Geode Capital Management
Massachusetts
$7.45M +$849K +21,480 +14%
Norges Bank
29
Norges Bank
Norway
$6.91M +$488K +12,353 +8%
ICM
30
IronBridge Capital Management
Illinois
$5.52M -$469K -11,860 -8%
ECP
31
Elk Creek Partners
Colorado
$4.95M -$1.63M -41,295 -26%
TCIM
32
TIAA CREF Investment Management
New York
$4.34M -$102K -2,568 -2%
FLAM
33
First Light Asset Management
Minnesota
$3.77M +$351K +8,879 +11%
BIM
34
BlackRock Investment Management
Delaware
$3.46M +$49.1K +1,242 +2%
Charles Schwab
35
Charles Schwab
California
$3.39M +$149K +3,757 +5%
HCMT
36
Highland Capital Management (Texas)
Texas
$3.38M +$2.69M +67,986 +556%
Principal Financial Group
37
Principal Financial Group
Iowa
$3.23M +$229K +5,801 +8%
PAM
38
Panagora Asset Management
Massachusetts
$3.13M -$215K -5,440 -7%
WSA
39
Wall Street Associates
California
$2.95M +$557K +14,089 +25%
CCM
40
Cadence Capital Management
Massachusetts
$2.92M +$2.74M +69,340 New
Ohio Public Employees Retirement System (OPERS)
41
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.79M +$170K +4,312 +7%
PAM
42
Paradigm Asset Management
New York
$2.75M -$573K -14,500 -18%
MAA
43
Managed Account Advisors
New Jersey
$2.55M +$113K +2,863 +5%
RJA
44
Raymond James & Associates
Florida
$2.3M -$197K -4,981 -8%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$2.22M -$1.04M -26,339 -33%
TI
46
Turner Investments
Pennsylvania
$2.22M +$2.09M +52,780 New
KIA
47
Kopp Investment Advisors
Minnesota
$2.19M +$108K +2,725 +6%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$2.16M -$31.6K -800 -2%
LCG
49
Lisanti Capital Growth
New York
$2.15M +$2.02M +50,995 New
VFA
50
Virtus Fund Advisers
Connecticut
$2.05M -$200K -5,057 -9%

LAB Hedge Fund Activity: Q1 2015 in Review

104 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2015, worth a combined $1.29B — up 26% from $1.02B a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new LAB positions and 11 closed out — a net gain of 5 holders — while 40 added to existing stakes and 36 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $15.6M. The largest seller was JP Morgan Chase, cutting an estimated $9.96M.

  • 104 institutional investors held Standard BioTools (LAB) as of Q1 2015, up from 100 in Q4 2014.
  • Funds reported $1.29B of Standard BioTools stock for Q1 2015, up 26% quarter-over-quarter.
  • 16 funds opened new Standard BioTools positions in Q1 2015 and 11 closed out, a net change of +5 holders.
  • The largest Standard BioTools buyer in Q1 2015 was Lord, Abbett & Co, an estimated $15.6M added.
  • The largest Standard BioTools seller in Q1 2015 was JP Morgan Chase, an estimated $9.96M sold.

Based on aggregated 13F filings for Q1 2015.